BioCardia Files 8-K: Other Events & Financials
Ticker: BCDA · Form: 8-K · Filed: Dec 4, 2024 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Dec 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 B |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, financials
TL;DR
BioCardia dropped an 8-K on Dec 4th - check it for company updates and financials.
AI Summary
BioCardia, Inc. filed an 8-K on December 4, 2024, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incorporated in Delaware and headquartered in Sunnyvale, California.
Why It Matters
This filing provides an update on BioCardia's corporate activities and financial reporting, which is crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing reporting general corporate events and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- Tiger X Medical, Inc. (company) — Former Company Name
- December 4, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Sunnyvale, California (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for BioCardia, Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of December 4, 2024.
When was BioCardia, Inc. incorporated, and where are its principal executive offices located?
BioCardia, Inc. is incorporated in Delaware and its principal executive offices are located at 320 Soquel Way, Sunnyvale, California 94085.
Has BioCardia, Inc. operated under any previous names?
Yes, BioCardia, Inc. was formerly known as Tiger X Medical, Inc., Cardo Medical, Inc., and CLICKNSETTLE COM INC.
What is the SEC file number and IRS Employer Identification Number for BioCardia, Inc.?
The SEC file number for BioCardia, Inc. is 001-38999, and its IRS Employer Identification Number is 23-2753988.
What is the SIC code for BioCardia, Inc. and what does it represent?
The Standard Industrial Classification (SIC) code for BioCardia, Inc. is 2836, which represents 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2024-12-04 08:30:21
Key Financial Figures
- $0.001 B — h registered Common Stock , par value $0.001 BCDA The Nasdaq Capital Market Indicat
Filing Documents
- bcda20241204_8k.htm (8-K) — 24KB
- ex_753977.htm (EX-99.1) — 8KB
- 0001437749-24-036648.txt ( ) — 163KB
- bcda-20241204.xsd (EX-101.SCH) — 3KB
- bcda-20241204_def.xml (EX-101.DEF) — 11KB
- bcda-20241204_lab.xml (EX-101.LAB) — 15KB
- bcda-20241204_pre.xml (EX-101.PRE) — 11KB
- bcda20241204_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On December 4, 2024, BioCardia, Inc. (the "Company") issued a press release announcing the successful completion of a consultation with Japan's Pharmaceutical and Medical Device Agency on the next steps for the submission for registration its lead therapeutic asset, BCDA-01, for the treatment of ischemic heart failure of reduced ejection fraction in Japan. A copy of the press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 BioCardia, Inc. press release dated December 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOCARDIA, INC. /s/ Peter Altman, Ph.D. Peter Altman, Ph.D. President and Chief Executive Officer Date: December 4, 2024